🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Participants Study

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects NCT07001436Phase 11 site📍 Beijing Henan Genuine Biotech Co., Ltd. · Tests: Azvudine tablets Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants NCT07636551NA1 site📍 Antwerp Institute of Tropical Medicine, Belgium · Tests: Skin punch biopsy, Blood samples A Clinical Study of HRS-7156 in Healthy Participants NCT07601087Phase 11 site📍 Shanghai Shandong Suncadia Medicine Co., Ltd. · Tests: HRS-7156, HRS-7156 placebo Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool NCT07483606n/a1 site📍 Istanbul Istanbul University - Cerrahpasa Safety and Pharmacokinetics of ALZ-507 in Healthy Elderly Adults NCT07824271Phase 11 site📍 Miami Alzheon Inc. · Tests: ALZ-507, Placebo Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects NCT05507164Phase 21 site📍 Newark Rutgers, The State University of New Jersey · Tests: Temporomasseteric Nerve Block A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes NCT06945406Phase 11 site📍 Neuss Eli Lilly and Company · Tests: LY4057996 SC, LY4057996 IV, Placebo SC, Placebo IV, Degludec SC Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon NCT07807891NA1 site📍 St. Petersburg Lyv Life Inc. (dba: Cora) · Tests: Tampon Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age NCT07516418Phase 16 sites📍 Griffith📍 Herston📍 Morayfield Sanofi · Tests: H5 Flu Investigational Medical Product (IMP) 1, H5 Flu IMP 2, H5 Flu IMP 3, RSV IMP 4, RSV IMP 5 A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants NCT07673120Phase 12 sites📍 Anaheim📍 Grayslake AbbVie · Tests: ABBV-313, Placebo, ABBV-313, Placebo A First-in-Human Single and Multiple Ascending Dose Study of MT-201 NCT07219368Phase 11 site📍 San Diego Mirador Therapeutics, Inc. · Tests: MT-201, Placebo A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) NCT06657768Phase 113 sites📍 Los Alamitos📍 Lady Lake📍 Maitland Eli Lilly and Company · Tests: LY4006895, Placebo A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure NCT07775495n/a51 sites📍 Birmingham📍 Anchorage📍 Phoenix Ecotera Health LLC Deep Phenotyping of CIndU NCT07359430n/a3 sites📍 Leiden📍 Rotterdam📍 Utrecht Centre for Human Drug Research, Netherlands A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site📍 Brisbane Climb Bio, Inc. · Tests: CLYM116, Placebo SAR447971 First-in-human Study NCT07629336Phase 11 site📍 Leiden Sanofi · Tests: SAR447971, Placebo A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. NCT07641634Phase 1, Phase 213 sites📍 Melbourne📍 Beijing📍 Guangzhou Prolium Bioscience, Inc · Tests: PRO-203, Placebo A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis NCT07526519Phase 11 site📍 Perth TrueLab Biopharmaceutical Co., Ltd · Tests: TL-003, Placebo A Phase 1 Study of Single and Multiple Ascending Doses of GV-100 NCT07788014Phase 11 site📍 Adelaide Gilva Therapeutics Inc. · Tests: GV-100, Placebo A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity NCT07665879Phase 12 sites📍 Neuss📍 Mölndal Eli Lilly and Company · Tests: Eloralintide, Placebo A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients NCT06946641Phase 11 site📍 Beijing Shanghai Qilu Pharmaceutical Research and Development Cente… · Tests: QLS12010, Placebo A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults NCT07013097Phase 11 site📍 Beijing Prime Gene Therapeutics Co., Ltd. · Tests: PG-033, PG-033 placebo comparator Muscle Vibration as a Countermeasure Against Hypoactivity-induced NCT07021079NA1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Focal muscle vibration, NO Focal muscle vibration A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) NCT06649110Phase 1, Phase 287 sites📍 Scottsdale📍 Orange📍 Stanford Novartis Pharmaceuticals · Tests: LTP, Placebo A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult NCT07632573Phase 11 site📍 Hangzhou Benethera (Shaoxing) Biotechnology Co., Ltd. · Tests: BDHK-2009 Tablets, Placebo A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients NCT06249919Phase 1, Phase 216 sites📍 Bucheon-si📍 Gwangju📍 Ilsan Neuracle Science Co., LTD. · Tests: NS101, Placebo A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. NCT07511205Phase 13 sites📍 Glendale📍 Brooklyn📍 Harrow AstraZeneca · Tests: AZD1043, Placebo A Clinical Study of SPH7854 Granules in Healthy Subjects. NCT06483373EARLY Phase 11 site📍 Chengdu Shanghai Pharmaceuticals Holding Co., Ltd · Tests: SPH7854, Placebo A Study to Evaluate MWN109 Injection in Healthy Subjects NCT06859853Phase 11 site📍 Melbourne Shanghai Minwei Biotechnology Co., Ltd · Tests: Placebo, Subcutaneous single and mutiple dose
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy